10x Genomics Inc (TXG) USD0.00001

Sell:$15.08Buy:$15.11$0.19 (1.28%)

NASDAQ:0.25%
Market closed | Prices delayed by at least 15 minutes
Sell:$15.08
Buy:$15.11
Change:$0.19 (1.28%)
Deal now
Market closed | Prices delayed by at least 15 minutes
Sell:$15.08
Buy:$15.11
Change:$0.19 (1.28%)
Market closed | Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables and software for analyzing biological systems. Its Chromium platform includes its Chromium X Series, Chromium Connect and legacy Chromium Controller instruments, microfluidic chips and related consumables, which enables throughput analysis of individual biological components. Its Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Its Xenium platform for in situ analysis is designed to give scientists the ability to not only locate and type cells in their tissue context. Its products include Chromium Single Cell Gene Expression, Chromium Single Cell Gene Expression Flex, Chromium Single Cell Immune Profiling, Chromium Single Cell assay for transposase accessible chromatin (ATAC), Chromium Single Cell Multiome ATAC + Gene Expression, Visium Spatial Gene Expression, and others.

Key people

Benjamin J. Hindson
President, Co-Founder, Chief Scientific Officer, Director
Serge Wilson Saxonov
Chief Executive Officer, Co-Founder, Director
Adam S. Taich
Chief Financial Officer
Mennah Moustafa
Chief Commercial Officer
Eric S. Whitaker
Chief Legal Officer
John R. Stuelpnagel
Independent Chairman of the Board
Sarah A. Teichmann
Director
Sridhar Kosaraju
Independent Director
Alan V. Mateo
Independent Director
Kimberly J. Popovits
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US88025U1097
  • Market cap
    $1.80bn
  • Employees
    1,259
  • Shares in issue
    107.00m
  • Exchange
    NASDAQ
  • Index
    TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.